ScieGen Pharmaceuticals, Inc Products: Prescription Medications Section, Page 8

RANOLAZINE

Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel…

ScieGen Pharmaceuticals, Inc24 January 2020

Rosuvastatin

Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity…

ScieGen Pharmaceuticals, Inc.13 January 2023

SOLIFENACIN SUCCINATE

Solifenacin succinate is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate is…

ScieGen Pharmaceuticals, Inc.19 January 2021

Valsartan

Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension, to lower blood pressure in adults and children 6 years and older. Lowering blood pressure reduces the…

ScieGen Pharmaceuticals, INC.9 January 2023

Page 8 of 8 « First Page « … 4 5 6 7 8

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.